Skip to main content

Table 3 Treatments and hospitalizations for patients within 1 year after lung cancer diagnosis

From: Could venous thromboembolism and major bleeding be indicators of lung cancer mortality? A nationwide database study

N (%) Total (N = 2553)Before VTE (N = 208)Before PE (N = 93)Before bleeding (N = 341)
Lung cancer surgeryNo2052 (80.4)181 (87.0)83 (89.3)280 (82.1)
 Yes501 (19.6)27 (13.0*)10 (10.8)61 (17.9)
Other surgeryNo1970 (77.2)156 (75.0)73 (78.5)279 (81.8)
 Yes583 (22.8)52 (25.0)20 (21.5)62 (18.2)
ChemotherapyNo1201 (47.0)72 (34.6)35 (37.6)217 (63.6)
 Yes1352 (53.0)136 (65.4)58 (62.4)124 (36.4)
+ BevacizumabNo1244 (92.0)125 (91.9)55 (91.4)117 (94.4)
 Yes108 (8.0)11 (8.1)3 (8.6)7 (5.7)
Oral lung cancer targeted therapyNo2340 (91.7)201 (96.6)87 (93.6)333 (97.7)
 Yes213 (8.3)7 (3.4)6 (6.5)8 (2.4)
RadiotherapyNo1711 (67.0)155 (74.5)68 (73.1)274 (80.4)
 Yes842 (33.0)53 (25.5)25 (26.9)67 (19.7)
Blood transfusionNo2253 (88.3)190 (91.4)86 (92.5)290 (85.0)
 Yes300 (11.8)18 (8.7)7 (7.5)51 (15.0)
Non-surgical hospitalisationNo1065 (41.7)122 (58.7)52 (55.9) 
 Yes1488 (58.3)86 (41.4)41 (44.1) 
  1. *Among patients with VTE, 13.0% underwent lung cancer surgery after the diagnosis of cancer and before the diagnosis of VTE
  2. Non-surgical stay of more than 2 nights